Results
Adamas Pharmaceuticals Inc.
12/01/2021 | Press release | Distributed by Public on 12/02/2021 05:15
Notice of Effectiveness (Form EFFECT)
Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 1, 2021 |
| Accession Number: | 0001104659-21-143413 | |||||
| Submission Type: | POS AM | |||||
|